Antitumor necrosis factor and anti-integrin agents may improve outcomes after liver transplantation among patients with inflammatory bowel disease or primary sclerosing cholangitis. Patients with ...
Aims: To describe the clinical features and outcomes of PSC-IBD and compare these to a group of chronic ulcerative colitis (CUC) patients. Methods: The medical records of all patients with PSC-IBD ...
New Inflammatory Bowel Disease Testing Protocol Could Speed Up Diagnosis Apr. 16, 2024 — Patients with suspected inflammatory bowel disease (IBD) could benefit from better testing protocols that ...
The partners will work on Treg therapies that can "re-establish immune tolerance and repair tissue" in IBD patients like ulcerative colitis and Crohn's disease, said GentiBio in a statement.
To “economically” weave the patient experience into the fabric of clinical trials, sponsors should consider two key factors: Although adapting to these two factors does take some ...
Objectives Explore how patient-reported experience measures (PREMs) are collected, communicated and used to inform quality improvement (QI) across healthcare settings. Design Systematic review.
This has resulted in the validation of several targets for the treatment of experimental inflammation—both on immune and non-immune cells—some of which have translated into effective treatments for ...